<?xml version="1.0" encoding="UTF-8"?>
<p id="p0020">The tested phytochemicals were: chrysoeriol-7-
 <italic>O</italic>-rutinoside (
 <bold>1</bold>), luteolin-7-
 <italic>O</italic>-rutinoside (
 <bold>2</bold>), chrysoeriol-7-
 <italic>O-β</italic>-
 <sub>D</sub>-glucopyranoside (
 <bold>3</bold>), Apigenin-7-
 <italic>O-β</italic>-
 <sub>D</sub>-glucopyranoside (
 <bold>4</bold>), luteolin-3′,4′-dimethoxylether-7-
 <italic>O-β</italic>-
 <sub>D</sub>-glucoside (
 <bold>5</bold>) and luteolin (
 <bold>6</bold>) (
 <xref rid="fig1" ref-type="fig">Figure 1</xref>). They were isolated from the dichloromethane (CH
 <sub>2</sub>Cl
 <sub>2</sub>): methanol (MeOH) (1:1) extract of the leaves of 
 <italic>Acacia sieberiana</italic> var Woodii (Fabaceae) as described below. Doxorubicin (purity: 98.0%) purchased from Sigma-Aldrich (Munich, Germany) was obtained from the Johannes Gutenberg University Medical Center (Mainz, Germany). Geneticin &gt;98% (used at 800 ng/mL and 400 μg/mL in culture media for MDA-MB-231 overexpressing breast cancer resistance protein 
 <italic>(BCRP),</italic> U87MG with deleted epidermal growth factor receptor 
 <italic>(EGFR)</italic> and HCT116 
 <italic>p53</italic>
 <sup>
  <italic>−/−</italic>
 </sup> respectively) was obtained from Sigma-Aldrich and stored at 72.18 mM. Hydrogen peroxide (H
 <sub>2</sub>O
 <sub>2</sub>) was purchased from Sigma-Aldrich (Taufkirchen, Germany). DMSO (Sigma-Aldrich) was used to dissolved the test samples and the final concentration in all experiments was not greater than 0.1%.
</p>
